NCT03568851 is a clinical trial in Breast Feeding, sponsored by University of California, Davis.

Who is sponsoring NCT03568851?

NCT03568851 is sponsored by University of California, Davis.

What condition does NCT03568851 study?

NCT03568851 studies Breast Feeding, Milk Expression, Breast, Amenorrhea, Postpartum.

Is NCT03568851 still recruiting?

NCT03568851 is currently completed. Last updated 18 August 2021.

Last reviewed 2021-08-18 · How we verify

NCT03568851

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reproductive Health Outcomes by Method of Breast Milk Feeding

Completed Last updated 18 August 2021

What this trial tests

trial in Breast Feeding in 394 participants. Completed in 14 January 2021.

Timeline

27 June 2018

Primary endpoint
14 January 2021

14 January 2021

Quick facts

Lead sponsor	University of California, Davis
Status	Completed
Study type	OBSERVATIONAL
Enrollment	394
Start date	27 June 2018
Primary completion	14 January 2021
Estimated completion	14 January 2021
Sites	1 location across United States

Conditions studied

Breast Feeding — all drugs for Breast Feeding →
Milk Expression, Breast — all drugs for Milk Expression, Breast →
Amenorrhea, Postpartum — all drugs for Amenorrhea, Postpartum →

Sponsor

University of California, Davis

Who can join

Adults 15 to 45, female only, with Breast Feeding or Milk Expression, Breast. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to determine whether there are differences in ovarian suppression between women who are feeding at the breast compared with women who are pumping. * In the main study, the aim is to compare reproductive health outcomes, including amenorrhea rates, duration of lactation, and resumption of sexual activity, between mothers who are exclusively breastfeeding (i.e. feeding at the breast) and those who are pumping after a term or preterm delivery. * In the sub-study, the aim is to determine the feasibility and acceptability of using urinary luteinizing hormone (LH) detection kits at home to detect ovulation in exclusively breastmilk feeding women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Feeding

Currently open trials in the same condition.

NCT07478341 — Hybrid Breastfeeding Education in Late Pregnancy: Effects on Antenatal Attachment and Breastfeeding · NA · recruiting
NCT07371845 — Effect of Teach-Back Education on Breastfeeding and Bonding in Mothers of Preterm Infants · NA · recruiting
NCT07281339 — Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women · NA · recruiting
NCT06621238 — The Effect of Musıc on Labor Paın, Anxıety and Breastfeedıng Success · NA · recruiting
NCT06691932 — At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN) · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03568851 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 18 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03568851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing